CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
1 Year Est. Return
+39.18%
AUM
$19.3B
AUM Growth
-$803M
(-4%)
Holding
738
Top Buys
| 1 | +$78.3M | |
| 2 | +$57M | |
| 3 | +$48M | |
| 4 |
Alibaba
BABA
|
+$43.4M |
| 5 |
Apple
AAPL
|
+$39M |
Top Sells
| 1 | +$87.5M | |
| 2 | +$45.5M | |
| 3 | +$44.5M | |
| 4 |
JPMorgan Chase
JPM
|
+$44.3M |
| 5 |
IQVIA
IQV
|
+$43M |
Sector Composition
| 1 | Technology | 32.73% |
| 2 | Healthcare | 27.11% |
| 3 | Financials | 9.44% |
| 4 | Consumer Discretionary | 7.72% |
| 5 | Communication Services | 7.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Ultragenyx Pharmaceutical
RARE
$2.22B
| $23M | 0.12% |
1,096,182
+296,798
|
|
||
177
CBRE Group
CBRE
$36.8B
| $22.7M | 0.12% |
167,770
+2,577
|
|
||
178
American International
AIG
$38.5B
| $22.6M | 0.12% |
300,112
+209,030
|
|
||
179
Cytokinetics
CYTK
$9.72B
| $22.1M | 0.11% |
335,208
+188,577
|
|
||
180
BioCryst Pharmaceuticals
BCRX
$2.08B
| $21.8M | 0.11% |
+2,286,841
|
|
||
181
Mineralys Therapeutics
MLYS
$2.02B
| $21.7M | 0.11% |
801,904
+123,517
|
|
||
182
Syndax Pharmaceuticals
SNDX
$1.64B
| $21.6M | 0.11% |
925,332
|
|
||
183
Estee Lauder
EL
$29.9B
| $21.6M | 0.11% |
301,032
+208,628
|
|
||
184
Coherent
COHR
$82.1B
| $21.2M | 0.11% |
89,135
+14,007
|
|
||
185
Oracle
ORCL
$665B
| $21.2M | 0.11% |
144,283
-1,943
|
|
||
186
Denali Therapeutics
DNLI
$3.08B
| $21.1M | 0.11% |
1,099,845
-66,534
|
|
||
187
Edwards Lifesciences
EW
$49.6B
| $20.8M | 0.11% |
260,327
+25,359
|
|
||
188
Futu Holdings
FUTU
$13.4B
| $20.8M | 0.11% |
152,249
-31,797
|
|
||
189
Vista Energy
VIST
$8.63B
| $20.8M | 0.11% |
+275,600
|
|
||
190
BridgeBio Pharma
BBIO
$12.7B
| $20.7M | 0.11% |
278,888
|
|
||
191
YPF
YPF
$21.8B
| $20.5M | 0.11% |
444,000
+297,000
|
|
||
192
Praxis Precision Medicines
PRAX
$7.62B
| $20.5M | 0.11% |
63,628
-46,962
|
|
||
193
lululemon athletica
LULU
$14.9B
| $20.5M | 0.11% |
133,856
+76,777
|
|
||
194
Quest Diagnostics
DGX
$21.4B
| $20.4M | 0.11% |
104,136
+2,409
|
|
||
195
First Solar
FSLR
$34B
| $20.3M | 0.11% |
102,792
-10,052
|
|
||
|
ORKA
196
Oruka Therapeutics
ORKA
$3.37B
| $20.2M | 0.1% |
411,006
+10,497
|
|
||
197
Veralto
VLTO
$20.4B
| $20.1M | 0.1% |
226,804
+15,839
|
|
||
198
Equinix
EQIX
$108B
| $19.8M | 0.1% |
20,218
+317
|
|
||
199
Manulife Financial
MFC
$63.6B
| $19.6M | 0.1% |
570,607
-145,439
|
|
||
200
IAMGOLD
IAG
$9.77B
| $19.2M | 0.1% |
1,020,000
-520,000
|
|